AMRN Amarin Corp Plc PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Amarin (AMRN) Stock: Buy, Sell, or Hold?

$11.71
-0.04 (-0.34%) â–ŧ
5d: -4.41% 30d: +1.12% 90d: -17.24%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (48%)
Quality Score
38/100
Position
FAIR
30-Day Fair Range
$11.52 – $12.21
Position: FAIR
Forward P/E & Valuation
-195.2x CHEAP
vs 17.3x historical avg
Wall Street Target
$13.00
+11.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$11.39 / $13.18
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: AMRN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When AMRN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: AMRN is currently trading at $11.71, which is considered fair relative to its 30-day fair value range of $11.52 to $12.21. From a valuation perspective, the stock is trading at a discount (Forward PE: -195.2) compared to its historical average (17.3). At these levels, the market is pricing in 0% annual earnings growth.

Technical Outlook: Technically, AMRN is in a strong downtrend. The price is currently testing key support at $11.39. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: AMRN scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.00 (+11.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $11.52 - $12.21
Company Quality Score 38/100 (SELL)
Volume Confirmation HIGH
Confidence Score 47.6%

Trading Range & Key Levels

30-Day Trading Range $11.52 - $12.21
Current vs Trading Range FAIR
Support Level $11.39
Resistance Level $13.18
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (30/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($13.00)
  • WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -195.17
Wall Street Target $13.00 (+11.0%)
Revenue Growth (YoY) -20.4%
Earnings Growth (YoY) -94.2%
Profit Margin -10.9%
PE vs Historical -195.2 vs 17.3 CHEAP
Share AMRN Analysis

Share this live AMRN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (AMRN)

Bearish 1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Mar 18, 2026
Daily AI digest
AI Retail Discussion Summary: Reddit & WallStreetBets discussions on AMRN are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:28 PM ET
Data refreshes hourly during market hours. Next update: 9:28 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for AMRN.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - General Stocks

Top-rated stocks in Drug Manufacturers - General by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ABBV
AbbVie Inc
STRONG BUY
29 analysts
$306 48 HOLD
BIIB
Biogen Inc
BUY
36 analysts
$266 43 HOLD
LLY
Eli Lilly and Company
STRONG BUY
31 analysts
$1453 27 SELL
MRK
Merck & Company Inc
BUY
28 analysts
$162 50 HOLD
GILD
Gilead Sciences Inc
STRONG BUY
28 analysts
$175 37 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive AMRN Research Pages
AMRN Technical Chart AMRN Price Prediction AMRN Intrinsic Value DCF AMRN Earnings Date AMRN Investment Advisor AMRN Fair Price Analyzer AMRN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals